Citations

Showing 10 of 108094 citations.

Gastrointestinal Glomus Tumors: Outcomes and Management Experiences
Zironda, Andrea , Thiels, Cornelius A.

Mayo Clinic

Journal of the American College of Surgeons | October 14, 2022 | Volume: 235 | Issue: 5 | Pages: S25-S26

10.1097/01.xcs.0000895828.43360.79 Get It

Operative Staff Perspectives of Surgeon Coping with Intraoperative Errors: “Staying Calm Is #1”
Rivera, Mariela , D’Angelo, Anne-Lise D. , D’Angelo, Jonathan D. , Kelley, Scott R. , Busch, Rebecca A.

Mayo Clinic

Journal of the American College of Surgeons | October 14, 2022 | Volume: 235 | Issue: 5 | Pages: S74-S75

10.1097/01.xcs.0000896336.82931.72 Get It

The Impact of Gender in Frail Patients after Primary Total Hip Arthroplasty
Zamanzadeh, Ryan S , Schwartz, Andy M, Wilson, Jacob M. , Aspang, Jesse Seilern und , Martin, John R.

Mayo Clinic

Journal of the American College of Surgeons | October 14, 2022 | Volume: 235 | Issue: 5 | Pages: S61-S61

10.1097/01.xcs.0000896208.14112.c3 Get It

Patient Race Significantly Impacts Postoperative Outcome in Total Hip Arthroplasty Patients
Zamanzadeh, Ryan S , Schwartz, Andy M, Wilson, Jacob M. , Aspang, Jesse Seilern und , Martin, John R.

Mayo Clinic

Journal of the American College of Surgeons | October 14, 2022 | Volume: 235 | Issue: 5 | Pages: S61-S61

10.1097/01.xcs.0000896204.00091.50 Get It

Effect of endoscopic sleeve gastroplasty on gastric emptying, motility and hormones: a comparative prospective study
Rizk, Monika, Gomez-Villa, Jacky, Edwards, Phillip K , Jaruvongvanich, Veeravich , Acosta, Andrés , Lake, David S. , Fidler, Jeff L. , Bharucha, Adil E. , Camilleri, Michael , Vargas, Eric J , Acosta, Andres , Lake, David, Fidler, Jeff, Bharucha, A E , Camilleri, M , Abu Dayyeh, Barham K , Vargas, Eric J. , Storm, Andrew C. , Fidler, Jeff L. , Dayyeh, Barham K. Abu

Mayo Clinic

Gut | October 14, 2022 | Volume: 72 | Issue: 6 | Pages: 1073-1080

10.1136/gutjnl-2022-327816 | PMID 36241388 Get It

Objective Endoscopic sleeve gastroplasty (ESG) has gained global adoption but our understanding of its mechanism(s) of action and durability of efficacy is limited. We sought to determine changes in gastric emptying (GE), gastric motility (GM), hormones and eating behaviours after ESG. Design A priori-designed single-centre substudy of a large US randomised clinical trial, adults with obesity were randomised to ESG or lifestyle interventions (LS) alone. We measured GE, hormones and weight loss and assessed eating behaviours. In a subset of ESG patients, we assessed GM. The primary outcome was the change in T1/2 (min) at 3 months, and secondary outcomes were changes in weight, GE, GM, hormones and eating behaviours. We used t-test analyses and regression to determine the association between GE and weight loss. Results 36 (ESG=18; LS=18) participated in this substudy. Baseline characteristics were similar between the two groups. At 3 months, T1/2 was delayed in the ESG group (n=17) compared with the LS group (n=17) (152.3±47.3 vs 89.1±27.9; p<0.001). At 12 months, T1/2 remained delayed in the ESG group (n=16) vs control group (n=14) (137±37.4 vs 90.1±23.4; p<0.001). Greater delays in GE at 3 months were associated with greater weight loss. GM was preserved and fasting ghrelin, glucagon-like peptide 1 and polypeptide YY significantly increased 18 months after ESG. Conclusion ESG promotes weight loss through several key mechanistic pathways involving GE and hormones while preserving GM. These findings further support clinical adoption of this technique for the management of obesity. Trial registration number NCT03406975.
Dementia with Lewy bodies: Impact of co‐pathologies and implications for clinical trial design
Toledo, Jon B. , Abdelnour, Carla , Rodríguez‐Porcel, Federico , Pilotto, Andrea , Wyman‐Chick, Kathryn A , Kane, Joseph , Taylor, Angela , Rongve, Arvid , Scholz, Sonja W. , Lewis, Simon J.G. , Group, the ISTAART Lewy body dementias Trial Methods Working, Scholz, Sonja W , Lewis, Simon J G , Weil, Rimona Sharon , Ferreira, Daniel , Grothe, Michel J. , Leverenz, James B. , Boeve, Bradley F. , Aarsland, Dag , McKeith, Ian G. , Leroi, Iracema , Taylor, John‐Paul , Group, the ISTAART Lewy body dementias Trial Methods Working

Mayo Clinic

Alzheimer's & Dementia | October 14, 2022 | Volume: 19 | Issue: 1 | Pages: 318-332

10.1002/alz.12814 | PMID 36239924 Get It

Abstract Dementia with Lewy bodies (DLB) is clinically defined by the presence of visual hallucinations, fluctuations, rapid eye movement (REM) sleep behavioral disorder, and parkinsonism. Neuropathologically, it is characterized by the presence of Lewy pathology. However, neuropathological studies have demonstrated the high prevalence of coexistent Alzheimer's disease, TAR DNA‐binding protein 43 (TDP‐43), and cerebrovascular pathologic cases. Due to their high prevalence and clinical impact on DLB individuals, clinical trials should account for these co‐pathologies in their design and selection and the interpretation of biomarkers values and outcomes. Here we discuss the frequency of the different co‐pathologies in DLB and their cross‐sectional and longitudinal clinical impact. We then evaluate the utility and possible applications of disease‐specific and disease‐nonspecific biomarkers and how co‐pathologies can impact these biomarkers. We propose a framework for integrating multi‐modal biomarker fingerprints and step‐wise selection and assessment of DLB individuals for clinical trials, monitoring target engagement, and interpreting outcomes in the setting of co‐pathologies.
Leveraging machine learning to ascertain the implications of preoperative body mass index on surgical outcomes for 282 patients with preoperative obesity and lumbar spondylolisthesis in the Quality Outcomes Database
Agarwal, Nitin , Chan, Andrew K. , Shabani, Saman , Bisson, Erica F. , Bydon, Mohamad , Glassman, Steven D. , Foley, Kevin T. , Shaffrey, Christopher I. , Potts, Eric A. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Park, Paul , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Asher, Anthony L. , Virk, Michael S. , Haid, Regis W., Chou, Dean , Mummaneni, Praveen V. , Aabedi, Alexander A. , Letchuman, Vijay

Mayo Clinic

Journal of Neurosurgery: Spine | October 14, 2022 | Volume: 38 | Issue: 2 | Pages: 182-191

10.3171/2022.8.spine22365 | PMID 36208428 Get It

OBJECTIVE Prior studies have revealed that a body mass index (BMI) ≥ 30 is associated with worse outcomes following surgical intervention in grade 1 lumbar spondylolisthesis. Using a machine learning approach, this study aimed to leverage the prospective Quality Outcomes Database (QOD) to identify a BMI threshold for patients undergoing surgical intervention for grade 1 lumbar spondylolisthesis and thus reliably identify optimal surgical candidates among obese patients. METHODS Patients with grade 1 lumbar spondylolisthesis and preoperative BMI ≥ 30 from the prospectively collected QOD lumbar spondylolisthesis module were included in this study. A 12-month composite outcome was generated by performing principal components analysis and k-means clustering on four validated measures of surgical outcomes in patients with spondylolisthesis. Random forests were generated to determine the most important preoperative patient characteristics in predicting the composite outcome. Recursive partitioning was used to extract a BMI threshold associated with optimal outcomes. RESULTS The average BMI was 35.7, with 282 (46.4%) of the 608 patients from the QOD data set having a BMI ≥ 30. Principal components analysis revealed that the first principal component accounted for 99.2% of the variance in the four outcome measures. Two clusters were identified corresponding to patients with suboptimal outcomes (severe back pain, increased disability, impaired quality of life, and low satisfaction) and to those with optimal outcomes. Recursive partitioning established a BMI threshold of 37.5 after pruning via cross-validation. CONCLUSIONS In this multicenter study, the authors found that a BMI ≤ 37.5 was associated with improved patient outcomes following surgical intervention. These findings may help augment predictive analytics to deliver precision medicine and improve prehabilitation strategies.
Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance
Ugarte‐Gil, Manuel F. , Alarcón, Graciela S. , Seet, Andrea M. , Izadi, Zara , Montgomery, Anna , Duarte‐García, Alí , Gilbert, Emily, Valenzuela-Almada, Maria O , Wise, Leanna , Sparks, Jeffrey A. , Hsu, Tiffany , Sirotich, Emily , Hausmann, Jonathan S. , Sufka, Paul , Grainger, Rebecca , Bhana, Suleman , Wallace, Zachary S. , Jacobsohn, Lindsay, Strangfeld, Anja , Mateus, Elsa F , Hyrich, Kimme L , Gossec, Laure , Lawson‐Tovey, Saskia , Kearsley‐Fleet, Lianne , Schaefer, Martin, Machado, Pedro , Schäfer, Martin , Ware, Anna , Gilbert, Emily L , Hsu, Tiffany Y-T , D'Silva, Kristin M , Patel, Naomi J , Sirotich, Emily , Liew, Jean , Hausmann, Jonathan S , Sufka, Paul , Grainger, Rebecca , Bhana, Suleman , Wallace, Zachary S , Strangfeld, Anja , Mateus, Elsa F , Hyrich, Kimme L , Gossec, Laure , Carmona, Loreto , Lawson-Tovey, Saskia , Kearsley-Fleet, Lianne , Schaefer, Martin , Machado, Pedro M , Robinson, Philip C , Gianfrancesco, Milena A , Yazdany, Jinoos , Alarcón, Graciela S. , Sparks, Jeffrey A , Duarte-García, Alí , Ugarte-Gil, Manuel F , Wise, Leanna M , Liew, Jean W. , Carmona, Loreto , Robinson, Philip C. , Yazdany, Jinoos

Mayo Clinic

Arthritis Care & Research | October 14, 2022 | Volume: 75 | Issue: 1 | Pages: 53-60

10.1002/acr.25039 | PMID 36239292 Get It

ObjectiveTo determine the association between race/ethnicity and COVID‐19 outcomes in individuals with systemic lupus erythematosus (SLE).MethodsIndividuals with SLE from the US with data entered into the COVID‐19 Global Rheumatology Alliance registry between March 24, 2020 and August 27, 2021 were included. Variables included age, sex, race, and ethnicity (White, Black, Hispanic, other), comorbidities, disease activity, pandemic time period, glucocorticoid dose, antimalarials, and immunosuppressive drug use. The ordinal outcome categories were: not hospitalized, hospitalized with no oxygenation, hospitalized with any ventilation or oxygenation, and death. We constructed ordinal logistic regression models evaluating the relationship between race/ethnicity and COVID‐19 severity, adjusting for possible confounders.ResultsWe included 523 patients; 473 (90.4%) were female and the mean ± SD age was 46.6 ± 14.0 years. A total of 358 patients (74.6%) were not hospitalized; 40 patients (8.3%) were hospitalized without oxygen, 64 patients (13.3%) were hospitalized with any oxygenation, and 18 (3.8%) died. In a multivariable model, Black (odds ratio [OR] 2.73 [95% confidence interval (95% CI) 1.36–5.53]) and Hispanic (OR 2.76 [95% CI 1.34–5.69]) individuals had higher odds of more severe outcomes than White individuals.ConclusionBlack and Hispanic individuals with SLE experienced more severe COVID‐19 outcomes, which is consistent with findings in the US general population. These results likely reflect socioeconomic and health disparities and suggest that more aggressive efforts are needed to prevent and treat infection in this population.
Safe heart flush technique during recovery from donors after circulatory death
Ahmed, Magdy M. El‐Sayed , Landolfo, Kevin , Jacob, Samuel , Sareyyüpoğlu, Başar , Thomas, Mathew , Pham, Si M. , Makey, Ian A. , Thomas, Mathew , El-Sayed Ahmed, Magdy M , Landolfo, Kevin P, Thomas, Mathew , Pham, Si

Mayo Clinic

Journal of Cardiac Surgery | October 14, 2022 | Volume: 37 | Issue: 12 | Pages: 5646-5648

10.1111/jocs.17023 | PMID 36229938 Get It

Management of Restenosis after Carotid Endarterectomy or Stenting
Paraskevas, Kosmas I. , Dardik, Alan , Gloviczki, Péter , Paraskevas, Kosmas I , Gloviczki, Péter

Mayo Clinic

Angiology | October 14, 2022 | Volume: 74 | Issue: 4 | Pages: 305-307

10.1177/00033197221133945 | PMID 36239036 Get It